Results 191 to 200 of about 1,541,306 (306)

Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2. [PDF]

Cardiovasc Diabetol, 2023
Kogan A, Grupper A, Sabbag A, Ram E, Jamal T, Nof E, Fisman EZ, Levin S, Beinart R, Frogel J, Raanani E, Sternik L.   +11 more
europepmc   +1 more source

Innovative insights into the effects of a high‐sucrose diet on pancreatic health and the therapeutic role of empagliflozin in type 2 diabetes: An experimental study

Animal Models and Experimental Medicine, EarlyView.
Histologic assessment of pancreatic tissues using the H&E method (Scale bar = 100 μm. Images were captured at 400×). A high‐sucrose diet induced structural damage in pancreatic tissue, whereas empagliflozin treatment markedly improved these histological alterations.
Emad Gholami, Ali Fardin, Fazeleh Iranshahi, Alireza Malek, Ali Saravani, Faranaz Aghvami, Houman Parsaei, Habib Yaribeygi   +7 more
wiley   +1 more source

The Role of Hypoxia-Sensitive <i>miRNA181a</i>, <i>miRNA199a</i>, <i>SIRT1</i>, and Adiponectin in Diabetes Mellitus Type 2 Development in Obstructive Sleep Apnea Patients. [PDF]

Int J Mol Sci
Karuga FF, Kaczmarski P, Sochal M, Szmyd B, Urbonaitė GV, Turkiewicz S, Białasiewicz P, Gabryelska A.   +7 more
europepmc   +1 more source

Adropin modulates pancreatic cell proliferation and glutathione levels in an animal model of type 1 diabetes mellitus

Animal Models and Experimental Medicine, EarlyView.
Adropin is related to the energy homeostasis‐associated gene. It significantly increased glutathione reductase enzyme levels in the pancreas of experimental diabetic rats. Adropin may reduce the severity of diabetes and its complications. Cell proliferation in the exocrine is reduced after the administration of adropin.
Ifrah I. Ali, Crystal D'Souza, Abderrahim Nemmar, Shreesh Ojha, Ernest A. Adeghate   +4 more
wiley   +1 more source

A Comparative Analysis of Clinical Features of Diabetes Mellitus Type 2 With Respect to Duration of Diabetes. [PDF]

Cureus
Kumar J, Rehman T, Barkat R, Shah BL, Sindhu L, Husnain M, Siddiqui MJ, Hashmi AA.   +7 more
europepmc   +1 more source

Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real‐World Evidence

Annals of Neurology, EarlyView.
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono, Bruce A.C. Cree, Stephen L. Hauser, Sergio E. Baranzini   +3 more
wiley   +1 more source

Erratum: The Correlation Between Macular Vessel Density and Its Clinical Parameters in Diabetes Mellitus Type 2 [Corrigendum]. [PDF]

Clin Ophthalmol
europepmc   +1 more source

Three decades of CKD due to diabetes mellitus type 2 in China, with projections of disease burden from 2022 to 2036: a systematic analysis for the Global Burden of Disease Study 2021. [PDF]

Clin Kidney J
He Y, Wang X, Wu Y, Li L, Liu M, Chen R, He J, Mai W, Li X.   +8 more
europepmc   +1 more source

Late Pregnancy Antiseizure Medication Exposure and Offspring Neurodevelopmental Risk: A Multi‐Child Cohort Study

Annals of Neurology, EarlyView.
Objective Antiseizure medication (ASM) use during pregnancy has increased over the past decade. However, evidence linking prenatal ASM exposure to neurodevelopmental disorders (NDDs) in offspring remains inconsistent. This study evaluated whether prenatal ASM exposure increases the risk of NDDs in children.
Odile Sheehy, Vanina Tchuente, Sherif Eltonsy, Steven Hawken, Padma Kaul, Mark Walker, Michael Pugliese, Roxana Dragan, Anamaria Savu, Lisiane Leal, Lucie Morin, Isabelle Malhamé, Raluca Pana, Anick Bérard   +13 more
wiley   +1 more source

Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study. [PDF]

BMC Gastroenterol
Rezazadeh M, Agah S, Kamyabi A, Akbari A, Ghamkhari Pisheh R, Eshraghi A, Babakhani A, Ahmadi A, Paseban M, Heidari P, Shirinkam I, Mehrdad A.   +11 more
europepmc   +1 more source